Rocket Lab: The SpaceX IPO Effect Makes It A Buy

Rocket Lab is a key beneficiary of the SpaceX public listing, with revenue growing 63.5% year-over-year to $200 million in Q1 2026. A record $2.2 billion backlog and strong liquidity support the investment case, driven by the Neutron rocket's potential to expand beyond the small-launch market.